Италија - Италијански - Ministero della Salute

izo s.r.l. a socio unico - benzil-penicillina sodica, streptomicina solfato - benzil-penicillina sodica - 600000 ui; streptomicina solfato - 0.5 g - beta-lactam antibacterials, penicillins, combinations with other antibacterials

Италија - Италијански - Ministero della Salute

eurovet animal health b.v. - penetamato iodidrato - penetamato iodidrato - 400 mg/ml - penethamate hydroiodide

Италија - Италијански - Ministero della Salute

laboratorios syva sau - benzil-penicillina procaina - benzil-penicillina procaina - 300 mg/ml, benzil-penicillina procainica - 300 mg/ml - procaine benzilpenicillin

Европска Унија - Италијански - EMA (European Medicines Agency)

mylan ire healthcare limited - pretomanid - tubercolosi, resistente ai farmaci multiresistenti - antimicobatterici - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). dovrebbero essere prese in considerazione le linee guida ufficiali sull'uso appropriato degli agenti antibatterici..

Италија - Италијански - Ministero della Salute

fatro s.p.a. - procaina benzil-penicillinato - procaina benzil-penicillinato - 300 mg/ml - procaine benzilpenicillin

Европска Унија - Италијански - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Европска Унија - Италијански - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori selettivi immunosoppressori - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Европска Унија - Италијански - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - preparazioni antianemiche - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Европска Унија - Италијански - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - agenti antineoplastici - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Италија - Италијански - AIFA (Agenzia Italiana del Farmaco)

teva b.v. - teriflunomide - teriflunomide